Dubsky, P <br/><br/>
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.  [electronic resource] 

 -  British journal of cancer  Dec 2013 
 - 2959-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2013.671  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anastrozole<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Cell Differentiation--physiology<br/>Cell Growth Processes--physiology<br/>Clinical Trials, Phase III as Topic<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Nitriles--administration & dosage<br/>Prognosis<br/>Proportional Hazards Models<br/>Randomized Controlled Trials as Topic<br/>Receptor, ErbB-2--biosynthesis<br/>Receptors, Estrogen--biosynthesis<br/>Retrospective Studies<br/>Signal Transduction<br/>Tamoxifen--administration & dosage<br/>Treatment Outcome<br/>Triazoles--administration & dosage